| BSE: 524735 | Sector: Health care |
| NSE: HIKAL | ISIN Code: INE475B01022 |
| BSE 00:00 | 24 Jan | 130.85 |
0 (0.00%) |
OPEN
131.40 |
HIGH
133.25 |
LOW
130.20 |
| NSE 00:00 | 24 Jan | 130.95 |
0.35 (0.27%) |
OPEN
131.00 |
HIGH
133.40 |
LOW
130.50 |
| OPEN | 131.40 |
| PREVIOUS CLOSE | 130.85 |
| VOLUME | 39003 |
| 52-Week high | 187.15 |
| 52-Week low | 100.75 |
| P/E | 15.16 |
| Mkt Cap.(Rs cr) | 1,613 |
| Buy Price | 130.85 |
| Buy Qty | 100.00 |
| Sell Price | 131.95 |
| Sell Qty | 50.00 |
Hikal was incorporated in 1988, with equity participation of Hiremaths, Kalyani Group, and subsequently Sumitomo Corporation of Japan. The manufacturing activities started at Mahad in 1991, at Taloja in 1998 and at Panoli in 2000. The company has expanded facilities of its existing products--MCA, PC, MNCB, etc, and diversified into the production of metoxuron technical, a wheat herbicide, whic...> More
| COMPANY INFORMATION | |||||||
| Director : | Baba Kalyani | ||||||
| Chairman & Managing Director : | Jai Hiremath | ||||||
| Joint Managing Director : | Sameer Hiremath | ||||||
| Independent Director : | Kannan Unni | ||||||
| Director : | Sugandha Hiremath | ||||||
| Independent Director : | Shivkumar Kheny | ||||||
| Independent Director : | Prakash V Mehta | ||||||
| Director : | Amit B Kalyani | ||||||
| Company Secretary : | Sham Wahalekar | ||||||
| Independent Director : | Ranjit Shahani | ||||||
| Addtnl Independent Director : | Shivani Bhasin Sachdeva | ||||||
| AUDITOR : | B S R & Co LLP/S R B C & Co LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Kalyani | ||||||
| Registered office | |||||||
| 717/718 Maker Chamber V, 7th Floor Nariman Point,Mumbai,Maharashtra-400021 | |||||||
| Ph : 91-022-3926 7100/62770477 | |||||||
| WEBSITE : http://www.hikal.com | |||||||
| E-mail : secretarial@hikal.com/info@hikal.com | |||||||
